Fig. 1. Cytometry gating strategy for identification of monocyte subpopulations
Fig. 2. Association of blood cytokine levels with circulating monocyte phenotype in breast cancer. А. Serum cytokine levels in patients with breast cancer and healthy women. B. Correlation of serum IL6 levels with the CD163+ and HLA-DR+ monocyte counts in breast cancer
Table 1. Clinical and morphological parameters of patients with breast cancer
Table 2. Correlation of individual features and tumor clinical and morphological parameters with the monocyte subpopulations in patients with BC
Note: BMI — body mass index.
Table 3. Association of the disease stage with phenotypic characteristics of monocytes in patients with BC
Table 4. Phenotypic characteristics of blood monocytes depending on the tumor molecular subtype
Note: TNBC — triple-negative breast cancer, Lum В — luminal В breast cancer, Her2+ –Her2neu-positive breast cancer